| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.38 | 0.01 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.006 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.23 | 0.0005 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-10 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-08 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.17 | 0.4 |